CHARLOTTE, NC--(Marketwired - June 20, 2016) - Encompass Compliance Corporation (OTC PINK: ENCC) announces that it has made an addition to its management team, hiring Mr. James Schoonover as its Chief Operating Officer.
James A. Schoonover, 59, comes to ENCC after a 16 year career with MEDTOX Scientific, which was sold to Laboratory Corporation of America in 2012. Schoonover has been involved in the drug and alcohol testing industry since 1987, having held both operating and marketing positions with companies involved in laboratory testing and specimen collection services.
Richard Sharp, CEO of Encompass, stated, "Jim Schoonover brings a very successful track record of growth and profitability to Encompass Compliance Corporation. His ability to profitably grow MEDTOX from $20 MM to $120 MM while providing clients with exceptional service was well recognized in the drug and alcohol testing industry. His public company experience will help Encompass, as we bring our new web-based compliance platform to market. I believe Jim will offer a fresh perspective and heightened communication capabilities to our valued shareholders."
Schoonover has an undergraduate degree from Cornell University in Ithaca, NY and an MBA from the University of St. Thomas in Minneapolis, MN.
About Encompass Compliance Corp.
Encompass Compliance Corp. is the most comprehensive provider of workplace drug, alcohol & marijuana compliance services. The company provides organizations with policies, procedures and training for supervisors and employees to manage their drug and alcohol testing programs. In addition Encompass provides claim defense services for your safety, risk and legal teams as well as information and content that supports your Human Resource and Drug Compliance Program Managers.
For additional information, view the company's website at www.encompinc.com and contact Mr. Richard Sharp at 866-328-7487 or firstname.lastname@example.org and https://www.encompinc.com/.
Disclosures in this press release may contain forward-looking statements relating to anticipated or expected events, activities, trends or results. Such forward-looking statements, include, but are not limited to, statements regarding the results and cost of the test well, potential offsets, future drilling activities, and other statements that are not historical facts. Forward-looking statements, can be identified by the use of forward looking terminology such as "believes," "suggests," "expects," "may," "goal," "estimates," "should," "likelihood," "plans," "targets," "intends," "could," or "anticipates," or the negative thereof, or other variations thereon, or comparable terminology, or by discussions of strategy or objectives. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties. Such statements are made to provide the public with management's current assessment of the Company's business, and it should not be assumed that actual results will prove these statements to be correct. Security holders are cautioned that such forward-looking statements involve risks and uncertainties. Certain factors may cause results to differ materially from those anticipated by some of the statements made in this release.